A host of new treatments that show promise in improving healing and hair growth, as well as reducing the appearance of scarring will now be offered to our CIT (Cole Isolation Technique) patients. CIT is a non-strip hair transplant procedure invented, and performed exclusively, by John P. Cole, MD. These new treatment offerings include ACell’s MatriStem, PRP (Platelet Rich Plasma), and micro-needling. All CIT patients are encouraged to take advantage of these promising new interventions.
ACell
ACell’s MatriStem regenerative medicine is creating huge buzz in the hair restoration industry. Matristem is a product that is primarily used to treat damaged tissue, and to minimize scar tissue formation. This FDA-approved technology encourages tissue formation at the site of damaged tissue. Unlike stem cell therapy, the use of MatriStem does not require the harvesting of tissue and is, therefore, much less costly than stem cell therapy. MatriStem will be used on CIT patients to significantly reduce patients’ post-op recovery time, permitting an even swifter return to daily activities. This product offers exciting promise to our hair transplant patients.
Platelet Rich Plasma (PRP)
PRP therapy involves the injection or topical application of plasma containing five times the amount of platelets found in circulating blood. PRP is derived from each patient’s own blood which is separated to form a high concentration of platelets containing over thirty growth factors. These factors have been shown to promote faster healing, collagen synthesis, and the formation of new blood vessels. When applied, PRP can enhance donor site wound healing, reduce donor scarring and enhance healing at the recipient site. We are exploring the possibility that PRP may help patients maintain their native hair, and possibly even improve graft yield following a hair transplant procedure. One study found that PRP treatment enhanced graft growth by as much as fifteen percent. Although we cannot predict the true value of these possibilities at this time, we are hopeful that we will uncover further benefits, such as these, with PRP therapy.
Micro-needling
Micro-needling is a collagen induction treatment that can be used to improve the appearance of scars. Tiny surgical steel needles on a hand-held roller are used to stimulate collagen production in the dermis layer (second layer of skin). Use of the roller causes collagen and elastin to be produced in the dermis as skin, and a small number of blood vessels, are pierced. Collagen and elsastin proteins directly improve the appearance of skin. This treatment will not typically cause swelling, and any trauma to the skin is minimal. Results from this process vary from patient to patient, but the treatment may be beneficial for patients with minor to extensive scarring in the donor area. Compared to other interventions, such as laser treatment, this process offers a much less expensive and invasive form of skin rejuvenation.
The Cole hair transplant group now offers Platelet Rich Plasma (PRP) to his patients. Platelet rich plasma, (PRP) is derived from the patient’s own blood and is rich in growth factors. Because it is derived from the blood, it is termed autologous and is safe. It is a cell based therapy using the patients own growth factors. The growth factors are concentrated however. The concentration of platelets is increased often over 5 times their natural concentration. This results in a super concentration of beneficial growth factors. The benefits of this therapy have been understood for years in many disciplines of medicine, but only recently have they been applied to hair restoration surgery and hair restoration in general. There are numerous reports that PRP promotes faster healing, but it is still to early to say that it increases hair coverage or a higher yield of graft growth.
Recently, Dr. John Cole met with surgeons in China. The meeting was scheduled in preparation of establishing a hair transplant center that offers economical CIT hair transplant method. The center will be headed by a team of hair transplant surgeons led and trained by Dr. Cole. At this time, several of the doctors have completed 6 months of on-the-job, one-on-one training.
Dr. Cole has already setup a clinic that offers CIT (Cole Isolation Technique) in Korea. The purpose of offering CIT in Asia is to educate other hair transplant doctors to produce excellent results with the minimally invasive procedure. Our operation in Korea is a part of our efforts to provide quality hair transplant surgery to all individuals in Asia. The most recent technology in CIT hair transplant surgery is created at the main office located in Atlanta, Georgia. The Cole Hair Transplant Group offices all have the same common goal of satisfying each patient and making their visit a wonderful experience.
For additional information on low-cost CIT in Korea & China, contact The Cole group: Contact Form. The Cole Hair Transplant Group offers free in-person consultations with Dr. Cole. The Cole Hair Transplant Group o
ffers 18+ years of hair transplant experience and provides high-quality hair transplant procedures. It also specializes in the non-strip scar method of hair transplant and reconstructive hair transplants.
This news originally posted on forhair.com in the following URL:
CIT in Asia news in forhair.com
I have a seemingly strange question. Has anyone tried taking advantage of medical donors with hair transplant procedure?
That’s a good question and one that we’ve thought about previously. I suspect one of the big concerns with this would be trying to match the donors. With life and death situation such as kidney and liver transplants, medical insurance will take care of the testing. With hair transplants, the procedure is not medically necessary so most insurance companies shy away from paying for hair transplant surgery. When someone dies, they check their organ donor status. If they are a donor, they are tested. If there is a suitable match in another state, the organs are air lifted to the patient. Such protocol for hair would be extremely expensive. Also, one often has immunosuppressive medications to prevent organ rejection. This would be quite expensive to the cosmetic surgery patient, as well since insurance companies would not pay the fee for on going immunosuppressant treatment.
